Total Funding
25
Total FundingPrivate Equity raised
Growth Score in past quarter
pts
Heat Score 25 in past quarter
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2198773
Vectura focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases.
Acquired by 

Phillips-Medisize
Trevor Phillips: COO
Karl Keegan: Chief Corporate Development Officer
About the Company
Vectura Group is a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. This growing market includes asthma and chronic obstructive pulmonary disease (COPD) and is estimated to be worth in excess of $30 billion worldwide.
